Cornerstone Advisors (Washington)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$388K Sell
2,624
-40
-2% -$6.19K 0.04% 58
2020
Q2
$437K Buy
2,664
+471
+21% +$72.3K 0.05% 49
2020
Q1
$304K Buy
2,193
+894
+69% +$123K 0.04% 52
2019
Q4
$171K Buy
1,299
+16
+1% +$1.85K 0.02% 110
2019
Q3
$143K Buy
1,283
+14
+1% +$1.56K 0.02% 113
2019
Q2
$141K Buy
1,269
+162
+15% +$19.1K 0.01% 201
2019
Q1
$144K Buy
1,107
+190
+21% +$23.1K 0.01% 177
2018
Q4
$106K Buy
917
+141
+18% +$15.8K 0.02% 187
2018
Q3
$83K Buy
776
+136
+21% +$13.6K 0.05% 240
2018
Q2
$55K Sell
640
-1,028
-62% -$84.4K 0.04% 283
2018
Q1
$129K Sell
1,668
-345
-17% -$27.8K 0.09% 164
2017
Q4
$170K Hold
2,013
0.11% 136
2017
Q3
$172K Hold
2,013
0.12% 131
2017
Q2
$166K Buy
2,013
+313
+18% +$25.5K 0.09% 126
2017
Q1
$143K Sell
1,700
-17
-1% -$1.36K 0.08% 147
2016
Q4
$126K Buy
1,717
+133
+8% +$9.9K 0.11% 148
2016
Q3
$127K Sell
1,584
-218
-12% -$17.4K 0.11% 136
2016
Q2
$142K Sell
1,802
-379
-17% -$28.5K 0.14% 80
2016
Q1
$157K Sell
2,181
-88
-4% -$6.66K 0.17% 76
2015
Q4
$191K Sell
2,269
-1,757
-44% -$146K 0.21% 62
2015
Q3
$337K Buy
4,026
+408
+11% +$34.4K 0.3% 50
2015
Q2
$302K Hold
3,618
0.25% 67
2015
Q1
$263K Buy
3,618
+12
+0.3% +$854 0.2% 81
2014
Q4
$249K Buy
3,606
+3,578
+12,779% +$242K 0.18% 91
2014
Q3
$2K Sell
28
-17
-38% -$1.08K ﹤0.01% 416
2014
Q2
$3K Hold
45
﹤0.01% 374
2014
Q1
$3K Buy
+45
New +$2.51K ﹤0.01% 325

Other funds holding LLY

Cornerstone Advisors (Washington)'s LLY Position: Q3 2020 in Review

Cornerstone Advisors (Washington) reduced its Eli Lilly (LLY) stake by 1.5% in Q3 2020, selling an estimated $6.19K and leaving 2,624 shares worth $388K. The position accounts for 0.04% of the portfolio, ranked #58.

Cornerstone Advisors (Washington) first reported a position in LLY in Q1 2014 and has held it in 27 quarters since. The position peaked at $437K in Q2 2020. 1,774 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

  • Cornerstone Advisors (Washington) held 2,624 shares of Eli Lilly worth $388K as of Q3 2020.
  • Cornerstone Advisors (Washington) sold 40 Eli Lilly shares in Q3 2020, an estimated $6.19K.
  • Eli Lilly made up 0.04% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #58 holding.
  • Cornerstone Advisors (Washington) first reported a position in Eli Lilly in Q1 2014 and has held it in 27 quarters since.
  • Cornerstone Advisors (Washington)'s Eli Lilly position peaked at $437K in Q2 2020.
  • 1,774 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.